Management of bone metastases from advanced renal cell carcinoma

被引：1
作者：
Khattak, Muhammad Adnan [1 ]
Martin, Hilary Laura [1 ]
机构：
[1] Royal Marsden NHS Trust, London SW3 6JJ, England
来源：
EUROPEAN JOURNAL OF CANCER | 2012年 / 48卷 / 16期
关键词：
SKELETAL-RELATED EVENTS; LONG-TERM EFFICACY; ZOLEDRONIC ACID; PREVENTIVE MEASURES; MULTIPLE-MYELOMA; BREAST-CANCER; DOUBLE-BLIND; OSTEONECROSIS; COMPLICATIONS; JAW;
D O I：
10.1016/j.ejca.2012.05.013
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：3123 / 3125
页数：3
相关论文
共 26 条
[1]   Cost-effectiveness of zoledronic acid in the prevention of skeletal-related events in patients with bone metastases secondary to advanced renal cell carcinoma: application to France, Germany, and the United Kingdom [J].
Botteman, M. F. ;
Meijboom, M. ;
Foley, I. ;
Stephens, J. M. ;
Chen, Y. M. ;
Kaura, S. .
EUROPEAN JOURNAL OF HEALTH ECONOMICS, 2011, 12 (06) :575-588
[2]   Osteonecrosis of the Jaw after a Single Bisphosphonate Infusion in a Patient with Metastatic Renal Cancer Treated with Sunitinib [J].
Bozas, George ;
Roy, Anu ;
Ramasamy, Vani ;
Maraveyas, Anthony .
ONKOLOGIE, 2010, 33 (06) :321-323
[3]  
Brown JE, 2003, AM J CANC, V2, P269
[4]   Worsening of osteonecrosis of the jaw during treatment with sunitinib in a patient with metastatic renal cell carcinoma [J].
Brunello, Antonella ;
Saia, Giorgia ;
Bedogni, Alberto ;
Scaglione, Daniela ;
Basso, Umberto .
BONE, 2009, 44 (01) :173-175
[5]   Effects of skeletal morbidities on longitudinal patient-reported outcomes and survival in patients with metastatic prostate cancer [J].
DePuy, Venita ;
Anstrom, Kevin J. ;
Castel, Liana D. ;
Schulman, Kevin A. ;
Weinfurt, Kevin P. ;
Saad, Fred .
SUPPORTIVE CARE IN CANCER, 2007, 15 (07) :869-876
[6]   Reduction of osteonecrosis of the jaw (ONJ) after implementation of preventive measures in patients with multiple myeloma treated with zoledronic acid [J].
Dimopoulos, M. A. ;
Kastritis, E. ;
Bamia, C. ;
Melakopoulos, I. ;
Gika, D. ;
Roussou, M. ;
Migkou, M. ;
Eleftherakis-Papaiakovou, E. ;
Christoulas, D. ;
Terpos, E. ;
Bamias, A. .
ANNALS OF ONCOLOGY, 2009, 20 (01) :117-120
[7]   Nonexposed Variant of Bisphosphonate-associated Osteonecrosis of the Jaw: A Case Series [J].
Fedele, Stefano ;
Porter, Stephen R. ;
D'Aiuto, Francesco ;
Aljohani, Suad ;
Vescovi, Paolo ;
Manfredi, Maddalena ;
Arduino, Paolo G. ;
Broccoletti, Roberto ;
Musciotto, Anna ;
Di Fede, Olga ;
Lazarovici, Tony S. ;
Campisi, Giuseppina ;
Yarom, Naom .
AMERICAN JOURNAL OF MEDICINE, 2010, 123 (11) :1060-1064
[8]   Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a randomised, double-blind study [J].
Fizazi, Karim ;
Carducci, Michael ;
Smith, Matthew ;
Damiao, Ronaldo ;
Brown, Janet ;
Karsh, Lawrence ;
Milecki, Piotr ;
Shore, Neal ;
Rader, Michael ;
Wang, Huei ;
Jiang, Qi ;
Tadros, Sylvia ;
Dansey, Roger ;
Goessl, Carsten .
LANCET, 2011, 377 (9768) :813-822
[9]  
Fleissig Y, 2012, ORAL SURG ORAL 0102
[10]   Osteonecrosis of the jaw (ONJ) risk in breast cancer patients after zoledronic acid treatment [J].
Fusco, Vittorio ;
Loidoris, Anastasios ;
Colella, Giuseppe ;
Vescovi, Paolo ;
Campisi, Giuseppina .
BREAST, 2010, 19 (05) :432-433
123